ReviewMaterials today. Bio2025
Harnessing marine-derived materials for therapeutics innovations: Advances in biomaterials from the ocean.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Methacrylation of Fibrillar Sea Urchin Collagen: Production of Sustainable, Stable, and Functional Hydrogels.ACS omega · 2026Article
- Bioactive Compounds of Ginger (Antibiotics (Basel, Switzerland) · 2026Review
- Proangiogenic and Collagen-Promoting Effects of a 70% Ethanol Extract ofInternational journal of molecular sciences · 2026Article
- Fabrication and Functional Modification Strategies of Squid Ink-Derived Nanoparticles: From Natural Melanin to Multifunctional Biomaterials.Marine drugs · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marine-derived biomaterials have gained increasing attention in recent years because of their distinct biochemical composition, biological functionality, and ecological sustainability. Extracted from diverse marine organisms such as algae, crustaceans, mollusks, and fish, these materials particularly polysaccharides, proteins, minerals, and lipids, exhibit favorable properties including biocompatibility, biodegradability, low immunogenicity, and intrinsic bioactivity. Their structural and functional diversity enables their use in a wide range of biomedical applications, including tissue engineering, drug delivery, wound healing, and regenerative medicine. This review provides a comprehensive overview of the current state of research on marine biomaterials, emphasizing their physicochemical properties, mechanisms of action, and biomedical potential. Particular attention is given to recent innovations, emerging challenges, and strategies for future development in the field of biomaterials. The integration of marine-derived components into biomedical systems not only enhances material performance but also offers new pathways for creating sustainable and clinically effective therapies. Through this analysis, we aim to highlight the promise of marine biomaterials as next-generation platforms in biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.